PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2.

Autor: Karim M; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA., Mishra M; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA., Lo CW; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA., Saul S; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA., Cagirici HB; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA., Tran DHN; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA., Agrawal A; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA., Ghita L; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA., Ojha A; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA., East MP; Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gammeltoft KA; Department of Infectious Diseases, University of Copenhagen, Denmark. Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen.; University Hospital-Hvidovre, Hvidovre, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Sahoo MK; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Johnson GL; Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Das S; Biomedical & Nutritional Science, Center for Pathogen Research & Training (CPRT), University of Massachusetts-Lowell, USA., Jochmans D; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Cohen CA; US Army Medical Research Institute of Infectious Diseases, Viral Immunology Branch, Frederick, Maryland, USA., Gottwein J; Department of Infectious Diseases, University of Copenhagen, Denmark. Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen.; University Hospital-Hvidovre, Hvidovre, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Dye J; US Army Medical Research Institute of Infectious Diseases, Viral Immunology Branch, Frederick, Maryland, USA., Neff N; Chan Zuckerberg Biohub, San Francisco, CA, 94158, USA., Pinsky BA; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Laitinen T; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Finland., Pantsar T; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Finland., Poso A; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Finland., Zanini F; School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; Cellular Genomics Futures Institute, UNSW Sydney, Sydney, New South Wales, Australia.; Evolution and Ecology Research Centre, UNSW Sydney, Sydney, New South Wales, Australia., Jonghe S; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Asquith CRM; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Finland., Einav S; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.; Chan Zuckerberg Biohub, San Francisco, CA, 94158, USA.; Department of Microbiology and Immunology, Stanford University, CA, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Apr 17. Date of Electronic Publication: 2024 Apr 17.

Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy.

Autor: Shao, Weihuan^1,2 (AUTHOR), Yao, Yiran^1,2 (AUTHOR), Yang, Ludi^1,2 (AUTHOR), Li, Xiaoran^1,2 (AUTHOR), Ge, Tongxin^1,2 (AUTHOR), Zheng, Yue^1,2 (AUTHOR), Zhu, Qiuyi^1,2 (AUTHOR), Ge, Shengfang^1,2 (AUTHOR), Gu, Xiang^1,2 (AUTHOR), Jia, Renbing^1,2 (AUTHOR) renbingjia@sjtu.edu.cn, Song, Xin^1,2 (AUTHOR) drsongxin_eye@163.com, Zhuang, Ai^1,2 (AUTHOR) aizh9h@163.com

Publikováno v: Experimental Hematology & Oncology. 4/3/2024, Vol. 13 Issue 1, p1-34. 34p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

High Reproducibility of ELISPOT Counts from Nine Different Laboratories.

Autor: Sundararaman S; Cellular Technology Limited, Shaker Hts. 44122, OH, USA. srividya.sundararaman@immunospot.com., Karulin AY; Cellular Technology Limited, Shaker Hts. 44122, OH, USA. ayk@immunospot.com., Ansari T; Cellular Technology Limited, Shaker Hts. 44122, OH, USA. tameem.ansari@immunospot.com., BenHamouda N; Européen Georges Pompidou, Paris 75015, France. nadine.benhamouda@egp.aphp.fr., Gottwein J; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical Research Centre, Copenhagen University Hospital, Hvidovre and Department of International Health, Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2650, Denmark. judith@gottwein.eu., Laxmanan S; Development Translational Medicine, Biogen Idec, Cambridge 02142, MA, USA. srilaxmanan@gmail.com., Levine SM; Immuno-Virology Drug Discovery, Bristol-Myers Squibb, Wallingford 06492, CT, USA. steven.m.levine@bms.com., Loffredo JT; Immuno-Sciences Biology Drug Discovery, Bristol-Myers Squibb, Princeton 08543, NJ, USA. John.Loffredo@bms.com., McArdle S; Nottingham Trent University, Nottingham NG118NS, UK. stephanie.mcardle@ntu.ac.uk., Neudoerfl C; Medizinische Hochschule Hannover 30625, Germany. Neudoerfl.Christine@mh-hannover.de., Roen D; Pharmasan Labs, Osceola 54020, WI, USA. diana.roen@pharmasan.com., Silina K; Cellular Technology Limited, Shaker Hts. 44122, OH, USA. karina@biomed.lu.lv., Welch M; Development Translational Medicine, Biogen Idec, Cambridge 02142, MA, USA. Mackenzie.Welch@biogenidec.com., Lehmann PV; Cellular Technology Limited, Shaker Hts. 44122, OH, USA. pvl@immunospot.com.

Publikováno v: Cells [Cells] 2015 Jan 09; Vol. 4 (1), pp. 21-39. Date of Electronic Publication: 2015 Jan 09.

Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis.

Autor: Nishiwaki, Ryo^1,2 (AUTHOR), Imoto, Ichiro¹ (AUTHOR), Oka, Satoko³ (AUTHOR), Yasuma, Taro^4,5 (AUTHOR), Fujimoto, Hajime^4,6 (AUTHOR), D'Alessandro-Gabazza, Corina N.^5,7 (AUTHOR), Toda, Masaaki⁵ (AUTHOR), Kobayashi, Tetsu^4,6 (AUTHOR), Osamu, Hataji⁸ (AUTHOR), Fujibe, Kodai⁹ (AUTHOR), Nishikawa, Kenichiro⁹ (AUTHOR), Hamaguchi, Tetsuya² (AUTHOR), Sugimasa, Natsuko² (AUTHOR), Noji, Midori² (AUTHOR), Ito, Yoshiyuki² (AUTHOR), Takeuchi, Kenji² (AUTHOR), Cann, Isaac^7,10,11 (AUTHOR), Inoue, Yasuhiro² (AUTHOR), Kato, Toshio² (AUTHOR), Gabazza, Esteban C.^4,5,7 (AUTHOR) gabazza@doc.medic.mie-u.ac.jp

Publikováno v: Gut Pathogens. 11/30/2023, Vol. 15 Issue 1, p1-15. 15p.